Use of Cefazolin for Group B Streptococci Prophylaxis in Women Reporting a Penicillin Allergy Without Anaphylaxis

Obstetrics and Gynecology

Volumn 127, Issue 3, 2016, Pages 577-583

  Briody, Victoria A ^a   Albright, Catherine M ^a   Has, Phinnara ^a   Hughes, Brenna L ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANAPHYLAXIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; APGAR SCORE; ARTICLE; BLOOD ANALYSIS; CESAREAN SECTION; DRUG USE; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HOSPITALIZATION; HUMAN; HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MEDICATION COMPLIANCE; MORBIDITY; NEWBORN PERIOD; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; CONTRAINDICATIONS; DRUG HYPERSENSITIVITY; NEWBORN; PREGNANCY; STATISTICS AND NUMERICAL DATA; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFAZOLIN; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INFANT, NEWBORN; PENICILLINS; PREGNANCY; RETROSPECTIVE STUDIES; STREPTOCOCCUS AGALACTIAE; YOUNG ADULT;

EID: 84960465677     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001297     Document Type: Article

References (25)

1. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991; 77:604-10.
2. Haberland CA, Benitz WE, Sanders GD, Pietzsch JB, Yamada S, Nguyen L, et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002;110:471-80.
3. Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. The Cochrane Database of Systematic Reviews 2014, Issue 6. Art. No.: CD007467. DOI: 10.1002/14651858.CD007467.pub4.
4. Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36.
5. Committee on Infectious Diseases; Committee on Fetus and Newborn, Baker CJ, Byington CL, Polin RA. Policy statement-Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics 2011;128:611-6.
6. Fiore Mitchell T, Pearlman MD, Chapman RL, Bhatt-Mehta V, Faix RG. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001;98:1075-9.
7. Allegaert K, van Mieghem T, Verbesselt R, de Hoon J, Rayyan M, Devlieger R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009;200:170.e1-7.
8. Popovic J, Grujic Z, Sabo A. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs. non-pregnant sectioned women. J Clin Pharm Ther 2007;32:595-602.
9. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360: 2626-36.
10. Paccione KA, Wiesenfeld HC. Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients. Infect Dis Obstet Gynecol 2013;2013:917304.
11. Peláez LM, Gelber SE, Fox NS, Chasen ST. Inappropriate use of vancomycin for preventing perinatal group B streptococcal (GBS) disease in laboring patients. J Perinat Med 2009;37:487-9.
12. Critchfield AS, Lievense SP, Raker CA, Matteson KA. Group B Streptococcus prophylaxis in patients who report a penicillin allergy: A follow-up study. Am J Obstet Gynecol 2011;204:150. e1-8.
13. Pacifici GM. Placental transfer of antibiotics administered to the mother: A review. Int J Clin Pharmacol Ther 2006;44:57-63.
14. Laiprasert J, Klein K, Mueller BA, Pearlman MD. Transplacental passage of vancomycin in noninfected term pregnant women. Obstet Gynecol 2007;109:1105-10.
15. Philipson A, Sabath LD, Charles D. Transplacental passage of erythromycin and clindamycin. N Engl J Med 1973;288: 1219-21.
16. Muller AE, Mouton JW, Oostvogel PM, Dörr PJ, Voskuyl RA, DeJongh J, et al. Pharmacokinetics of clindamycin in pregnant women in the peripartum period. Antimicrob Agents Chemother 2010;54:2175-81.
17. Ferrieri P, Lynfield R, Creti R, Flores AE. Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000-2010. Emerg Infect Dis 2013;19:551-8.
18. Lambiase A, Agangi A, Del Pezzo M, Quaglia F, Testa A, Rossano F, et al. In vitro resistance to macrolides and clindamycin by Group B Streptococcus isolated from pregnant and nonpregnant women. Infect Dis Obstet Gynecol 2012;2012: 913603.
19. Back EE, O'Grady EJ, Back JD. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother 2012;56:739-42.
20. Blaschke AJ, Pulver LS, Korgenski EK, Savitz LA, Daly JA, Byington CL. Clindamycin-resistant group B Streptococcus and failure of intrapartum prophylaxis to prevent early-onset disease. J Pediatr 2010;156:501-3.
21. Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240-6.
22. Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA 2001;285:2498-505.
23. Wong BB, Keith PK, Waserman S. Clinical history as a predictor of penicillin skin test outcome. Ann Allergy Asthma Immunol 2006;97:169-74.
24. Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 2013;1:258-63.
25. Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: A literature review. J Emerg Med 2012;42:612-20.